Clinical Trials Browser

Completed × Endometrial Adenocarcinoma × Genitourinary × Clear all

NCT01642082 2018-03-13

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

28 enrolled 9 charts

GenitourinaryGynecologic

Endometrial Adenocarcinoma

NCT00888173 2017-12-06

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

45 enrolled 10 charts

GenitourinaryGynecologic

Endometrial Adenocarcinoma

NCT01225887 2017-10-09

Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

37 enrolled 11 charts

GenitourinaryGynecologic

Endometrial Adenocarcinoma